Clinical utility of targeted treatments in the management of epithelial ovarian cancer

by Twu, Cheryl, Han, Ernest S
Published 2012

Dissection of De Novo Membrane Insertion Activities of Internal Transmembrane Segments of ATP-Binding-Cassette Transporters: Toward Understanding Topological Rules for Membrane Ass...

by Zhang, Jian-Ting, Chen, Mingang, Han, Ernest, Wang, Changsen
Published 1998

Origin pairing (‘handcuffing’) as a mode of negative control of P1 plasmid copy number

by Park, Kyusung, Han, Ernest, Paulsson, Johan, Chattoraj, Dhruba K.
Published 2001

Practical considerations in ovarian cancer chemotherapy

by Cristea, Mihaela, Han, Ernest, Salmon, Lennie, Morgan, Robert J.
Published 2010

Management of pelvic floor disorder in a diethylstilbestrol daughter

by Chung, Christopher P., Cao, Suzanne, Wakabayashi, Grace, Han, Ernest S.
Published in Proc (Bayl Univ Med Cent) (2017)

L1CAM is an independent predictor of poor survival in endometrial cancer – an analysis of The Cancer Genome Atlas (TCGA)

by Dellinger, Thanh H., Smith, David D., Ouyang, Ching, Warden, Charles D., Williams, John C., Han, Ernest S.
Published in Gynecol Oncol (2016)

Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer

by Wen, Wei, Lowe, Gina, Roberts, Cai M., Finlay, James, Han, Ernest S., Glackin, Carlotta A., Dellinger, Thanh H.
Published in Sci Rep (2017)

Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer

by Han, Ernest S., Wen, Wei, Dellinger, Thanh H., Wu, Jun, Lu, Selena A., Jove, Richard, Yim, John H.
Published in Oncotarget (2018)

Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway

by Wen, Wei, Lowe, Gina, Roberts, Cai M., Finlay, James, Han, Ernest S., Glackin, Carlotta A., Dellinger, Thanh Hue
Published in Int J Mol Sci (2018)

Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer

by Wen, Wei, Han, Ernest S., Dellinger, Thanh H., Lu, Leander X., Wu, Jun, Jove, Richard, Yim, John H.
Published in Cancers (Basel) (2020)

Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancer

by Yuan, Yuan, Wen, Wei, Yost, Susan E., Xing, Quanhua, Yan, Jin, Han, Ernest S., Mortimer, Joanne, Yim, John H.
Published in Sci Rep (2019)

Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer

by Wen, Wei, Han, Ernest S., Dellinger, Thanh H., Wu, Jun, Guo, Yuming, Buettner, Ralf, Horne, David A., Jove, Richard, Yim, John H.
Published in Transl Oncol (2019)

Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

by Eng, Oliver S., Dumitra, Sinziana, O’Leary, Michael, Raoof, Mustafa, Wakabayashi, Mark, Dellinger, Thanh H., Han, Ernest S., Lee, Stephen J., Paz, I. Benjamin, Lee, Byrne
Published in JAMA Surg (2017)

Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer

by Wen, Wei, Wu, Jun, Liu, Lucy, Tian, Yan, Buettner, Ralf, Hsieh, Meng-Yin, Horne, David, Dellinger, Thanh H, Han, Ernest S, Jove, Richard, Yim, John H
Published in Mol Cancer (2015)

A prospective study of protein excretion using short-interval timed urine collections in patients with lupus nephritis

by Fine, Derek M., Ziegenbein, Martina, Petri, Michelle, Han, Ernest C., McKinley, Alison M., Chellini, Jerry W., Nagaraja, Haikady N., Carson, Kathryn A., Rovin, Brad H.
Published 2009

PREDICTIVE AND PROGNOSTIC ANGIOGENIC MARKERS IN A GYNECOLOGIC ONCOLOGY GROUP PHASE II TRIAL OF BEVACIZUMAB IN RECURRENT AND PERSISTENT OVARIAN OR PERITONEAL CANCER

by Han, Ernest S., Burger, Robert A., Darcy, Kathleen M., Sill, Michael W., Randall, Leslie M., Chase, Dana, Parmakhtiar, Basmina, Monk, Bradley J., Greer, Benjamin E., DeGeest, Koen, Fruehauf, John P.
Published 2010

Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast Cancer

by Wen, Wei, Marcinkowski, Emily, Luyimbazi, David, Luu, Thehang, Xing, Quanhua, Yan, Jin, Wang, Yujun, Wu, Jun, Guo, Yuming, Tully, Dylan, Han, Ernest S., Yost, Susan E., Yuan, Yuan, Yim, John H.
Published in Cells (2019)

Intraperitoneal Administration of Neural Stem Cell-Nanoparticle Conjugates Targets Chemotherapy to Ovarian Tumors

by Cao, Pengpeng, Mooney, Rachael, Tirughana, Revathiswari, Abidi, Wafa, Aramburo, Soraya, Flores, Linda, Gilchrist, Megan, Nwokafor, Ugochi, Haber, Tom, Tiet, Pamela, Annala, Alexander J., Han, Ernest, Dellinger, Thanh, Aboody, Karen S., Berlin, Jacob M.
Published in Bioconjug Chem (2017)

Allogeneic human neural stem cells for improved therapeutic delivery to peritoneal ovarian cancer

by Mooney, Rachael, Abidi, Wafa, Batalla-Covello, Jennifer, Ngai, Hoi Wa, Hyde, Caitlyn, Machado, Diana, Abdul-Majid, Asma, Kang, Yanan, Hammad, Mohamed, Flores, Linda, Copeland, Greg, Dellinger, Thanh, Han, Ernest, Berlin, Jacob, Aboody, Karen S.
Published in Stem Cell Res Ther (2021)

Specific targeting of ovarian tumor-associated macrophages by large, anionic nanoparticles

by Haber, Tom, Cornejo, Yvonne R., Aramburo, Soraya, Flores, Linda, Cao, Pengpeng, Liu, Alice, Mooney, Rachael, Gilchrist, Megan, Tirughana, Revathiswari, Nwokafor, Ugochi, Abidi, Wafa, Han, Ernest, Dellinger, Thanh, Wakabayashi, Mark T., Aboody, Karen S., Berlin, Jacob M.
Published in Proc Natl Acad Sci U S A (2020)